Natural killer cell tolerance: control by self or self-control?
暂无分享,去创建一个
[1] Baptiste N. Jaeger,et al. Confinement of Activating Receptors at the Plasma Membrane Controls Natural Killer Cell Tolerance , 2011, Science Signaling.
[2] Ernesto Merino,et al. Inhibitory signaling blocks activating receptor clustering and induces cytoskeletal retraction in natural killer cells , 2011, The Journal of cell biology.
[3] M. Caligiuri,et al. Innate or Adaptive Immunity? The Example of Natural Killer Cells , 2011, Science.
[4] F. Vély,et al. Natural killer cells in human autoimmune diseases , 2010, Immunology.
[5] D. Raulet,et al. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment , 2010, The Journal of experimental medicine.
[6] W. Yokoyama,et al. MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environment , 2010, The Journal of experimental medicine.
[7] Y. Dor,et al. The activating receptor NKp46 is essential for the development of type 1 diabetes , 2010, Nature Immunology.
[8] S. Jonjić,et al. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. , 2009, Immunity.
[9] É. Vivier,et al. Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo , 2009, Proceedings of the National Academy of Sciences.
[10] É. Vivier,et al. NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model 1 , 2009, The Journal of Immunology.
[11] P. Brodin,et al. NK cell education: not an on-off switch but a tunable rheostat. , 2009, Trends in immunology.
[12] G. Leclercq,et al. A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education. , 2009, Immunity.
[13] Sofia Johansson,et al. The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells. , 2009, Blood.
[14] Joseph C. Sun,et al. Cutting Edge: Viral Infection Breaks NK Cell Tolerance to “Missing Self”1 , 2008, The Journal of Immunology.
[15] P. Brodin,et al. Beyond licensing and disarming: A quantitative view on NK‐cell education , 2008, European journal of immunology.
[16] Liping Yang,et al. Continuous engagement of a self-specific activation receptor induces NK cell tolerance , 2008, The Journal of experimental medicine.
[17] Joseph C. Sun,et al. Tolerance of NK cells encountering their viral ligand during development , 2008, The Journal of experimental medicine.
[18] Lewis L Lanier,et al. Up on the tightrope: natural killer cell activation and inhibition , 2008, Nature Immunology.
[19] Eric Vivier,et al. Functions of natural killer cells , 2008, Nature Immunology.
[20] É. Vivier,et al. Sustained NKG2D engagement induces cross-tolerance of multiple distinct NK cell activation pathways. , 2008, Blood.
[21] J. Klein,et al. Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT. , 2007, Blood.
[22] W. Yokoyama,et al. Licensing of natural killer cells by self‐major histocompatibility complex class I , 2006, Immunological reviews.
[23] D. Middleton,et al. Human NK cell education by inhibitory receptors for MHC class I. , 2006, Immunity.
[24] D. Raulet. Missing self recognition and self tolerance of natural killer (NK) cells. , 2006, Seminars in immunology.
[25] W. Yokoyama,et al. How do natural killer cells find self to achieve tolerance? , 2006, Immunity.
[26] A. Hayday,et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance , 2005, Nature Immunology.
[27] L. Lybarger,et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules , 2005, Nature.
[28] R. Vance,et al. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. , 2005, Blood.
[29] P. Parham. MHC class I molecules and kirs in human history, health and survival , 2005, Nature Reviews Immunology.
[30] Eric Vivier,et al. Natural Killer Cell Signaling Pathways , 2004, Science.
[31] Christophe Benoist,et al. Natural killer cells distinguish innocuous and destructive forms of pancreatic islet autoimmunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[32] J. Zimmer,et al. Cis association of Ly49A with MHC class I restricts natural killer cell inhibition , 2004, Nature Immunology.
[33] J. Ortaldo,et al. NK-cell purging of leukemia: superior antitumor effects of NK cells H2 allogeneic to the tumor and augmentation with inhibitory receptor blockade. , 2003, Blood.
[34] D. F. Barber,et al. Vav1 Phosphorylation Is Induced by β2 Integrin Engagement on Natural Killer Cells Upstream of Actin Cytoskeleton and Lipid Raft Reorganization , 2003, The Journal of experimental medicine.
[35] J. Zimmer,et al. Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells. , 2002, Blood.
[36] W. Murphy,et al. Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo. , 2001, Blood.
[37] W. Fridman,et al. Molecular Basis of the Recruitment of the SH2 Domain-containing Inositol 5-Phosphatases SHIP1 and SHIP2 by FcγRIIB* , 2000, The Journal of Biological Chemistry.
[38] J. Dorfman,et al. Acquisition of Ly49 Receptor Expression by Developing Natural Killer Cells , 1998, The Journal of experimental medicine.
[39] J. Zimmer,et al. Activity and Phenotype of Natural Killer Cells in Peptide Transporter (TAP)-deficient Patients (Type I Bare Lymphocyte Syndrome) , 1998, The Journal of experimental medicine.
[40] J. Dorfman,et al. The basis for self-tolerance of natural killer cells in beta2-microglobulin- and TAP-1- mice. , 1997, Journal of Immunology.
[41] C. Bieberich,et al. Natural Killer Cell Tolerance in Mice with Mosaic Expression of Major Histocompatibility Complex Class I Transgene , 1997, The Journal of experimental medicine.
[42] D. Raulet,et al. Class I-deficient hemopoietic cells and nonhemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. , 1997, Journal of immunology.
[43] P. Parham,et al. Killer cell receptors: keeping pace with MHC class I evolution , 1997, Immunological reviews.
[44] D. Marguet,et al. Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases. , 1996, Journal of immunology.
[45] R. Welsh,et al. NK cell response to viral infections in beta 2-microglobulin-deficient mice. , 1995, Journal of immunology.
[46] H. Ljunggren,et al. Recognition of beta 2-microglobulin-negative (beta 2m-) T-cell blasts by natural killer cells from normal but not from beta 2m- mice: nonresponsiveness controlled by beta 2m- bone marrow in chimeric mice. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[47] R. Jaenisch,et al. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. , 1991, Science.
[48] R. Jaenisch,et al. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice , 1991, Nature.
[49] H. Ljunggren,et al. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.
[50] Lewis L Lanier,et al. NK cell recognition. , 2005, Annual review of immunology.
[51] D. Margulies,et al. Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. , 2002, Annual review of immunology.
[52] W. Murphy,et al. NK inhibitory-receptor blockade for purging of leukemia: effects on hematopoietic reconstitution. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[53] R. Vance,et al. Regulation of the natural killer cell receptor repertoire. , 2001, Annual review of immunology.
[54] K. Tadokoro,et al. Tolerance of NK and LAK activity for HLA class I-deficient targets in a TAP1-deficient patient (bare lymphocyte syndrome type I). , 1999, Human immunology.
[55] Eric O Long,et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. , 1996, Immunity.